Toosendanin induces hepatotoxicity by restraining autophagy and lysosomal function through inhibiting STAT3/CTSC axis

Toosendanin (TSN) is the main active component in the traditional herb Melia toosendan Siebold & Zucc, which exhibits promising potential for development due to its diverse pharmacological properties. However, the hepatotoxicity associated with TSN needs further investigation. Previous research has implicated Autophagy dysregulation in TSN-induced hepatotoxicity, yet the underlying mechanisms remain elusive. In this study, the mechanisms of signal transducer and activator of transcription 3 (STAT3) in TSN-induced Autophagy inhibition and liver injury were explored using STAT3 knockout C57BL/6 mice and HepG2 cells. TSN decreased cell viability, increased Lactate Dehydrogenase (LDH) production in vitro, and elevated serum aspartate transaminase (AST) and alanine aminotransferase (ALT) levels as well as liver lesions in vivo, suggesting TSN had significant hepatotoxicity. TSN inhibited Janus kinase 2 (JAK2)/STAT3 pathway and the expression of Cathepsin C (CTSC). Inhibition of STAT3 exacerbated TSN-induced Autophagy inhibition and hepatic injury, whereas activation of STAT3 attenuated these effects of TSN. Mechanistically, STAT3 transcriptionally regulated the level of CTSC gene, which in turn affected Autophagy and the process of liver injury. TSN-administered STAT3 knockout mice showed more severe hepatotoxicity, CTSC downregulation, and Autophagy blockade than wildtype mice. In summary, TSN caused hepatotoxicity by inhibiting STAT3/CTSC axis-dependent Autophagy and lysosomal function.

Autophagy; Cathepsin C; Hepatotoxicity; Lysosome; Signal transducer and activator of transcription 3; Toosendanin.